Knowledge Action Portal on NCDs

Access the KAP Knowledge Repository

Readily access selected guidelines, reports and other knowledge resources to enhance evidence-informed, multisectoral, and multistakeholder initiatives in NCD prevention and control – curated by WHO's Global NCD Platform and supported by GCM Participants.

Is our repository missing your resource?

Submit your resource to the KAP

Narrow and customize your search results using the filter function

1491 Resources
Short
<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> WHO statement: Tobacco use and COVID-19 <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Health Organization

WHO statement: Tobacco use and COVID-19

Publication

11 May 2020

Tobacco kills more than 8 million people globally every year. More than 7 million of these deaths are from direct tobacco use and around 1.2 million are due to non-smokers being exposed to second-hand smoke. Tobacco smoking is a known risk factor for many respiratory infections and increases the severity of respiratory diseases. A review of studies by public health experts convened by WHO on 29 Ap...

PublicationTobacco use

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Health Organization

COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers

Article

08 May 2020

Concerns exists that angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin receptor blockers (ARBs) increase susceptibility to coronavirus SARS CoV-2 (the viral agent that causes the disease COVID-19) and the likelihood of severe COVID-19 illness.&nbsp;These concerns are based on considerations of biological plausibility,&nbsp;and the observation that there is an overrepresenta...

ArticleCardiovascular DiseaseCommunicable diseases

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> Policy Brief: A Disability-Inclusive Response to COVID-19 <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Health Organization

Policy Brief: A Disability-Inclusive Response to COVID-19

Briefs & Fact Sheets

06 May 2020

The global crisis of COVID-19 is deepening pre-existing inequalities, exposing the extent of exclusion and highlighting that work on disability inclusion is imperative. People with disabilities—one billion people— are one of the most excluded groups in our society and are among the hardest hit in this crisis in terms of fatalities. &nbsp;

Briefs & Fact SheetsCommunicable diseasesDisability and rehabilitationGender, equity and human rightsSocial determinants of health

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> Frequently Asked Questions: Breastfeeding and COVID-19- For health care workers <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Health Organization

Frequently Asked Questions: Breastfeeding and COVID-19- For health care workers

Guide

04 May 2020

The interim guidance and FAQ reflect: i. the available evidence regarding transmission risks of COVID-19 through breastmilk; ii. the protective effects of breastfeeding and skin-to-skin contact, and, iii. the harmful effects of inappropriate use of infant formula milk. The FAQ also draws on other WHO recommendations on Infant and Young Child Feeding and the Interagency Working Group Operational Gu...

GuideCommunicable diseasesMaternal, newborn, child and adolescent health

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> New FAQs address healthcare workers questions on breastfeeding and COVID-19 <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Health Organization

New FAQs address healthcare workers questions on breastfeeding and COVID-19

Article

04 May 2020

Mothers and healthcare workers who support them have many questions and concerns about whether it is safe for mothers with confirmed or suspected COVID-19 to be close to and breastfeed their babies during the pandemic. To address their questions, WHO has released a list of Frequently asked questions: Breastfeeding and COVID-19.

ArticleCommunicable diseasesMaternal, newborn, child and adolescent health

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> Q&A on COVID-19 and breastfeeding <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Health Organization

Q&A on COVID-19 and breastfeeding

Fact sheet

04 May 2020

A Q&amp;A page on COVID-19 and breastfeeding. &nbsp; &nbsp;

Fact sheetCommunicable diseasesMaternal, newborn, child and adolescent health

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19 <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Health Organization

The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19

01 May 2020

Concerns have been raised that NSAIDs may be associated with an increased risk of adverse effects when used in patients with acute viral respiratory infections, including COVID-19.1,2 This review aimed to assess the effects of prior and current use of NSAIDs in patients with acute viral respiratory infections on acute severe adverse events (including mortality, the acute respiratory distress syndr...

Communicable diseases

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> How to Overcome the Challenges Faced with PEN Services in Myanmar – HelpAge International (April 2020) <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

HelpAge International

How to Overcome the Challenges Faced with PEN Services in Myanmar – HelpAge International (April 2020)

Briefs & Fact Sheets

30 Apr 2020

This policy brief examines the implementation of the WHO Package of Essential Non-Communicable Disease Interventions (PEN) across Myanmar’s 330 townships and identifies key operational challenges such as supply chain gaps, training limitations, low public awareness, and inconsistent service quality. Drawing on implementation experience and research, it puts forward targeted recommendations to ex...

Briefs & Fact SheetsNCD LabHealthy Aging

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> Doing What Matters in Times of Stress: An Illustrated Guide <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Health Organization

Doing What Matters in Times of Stress: An Illustrated Guide

Guide

29 Apr 2020

Stress management guide for coping with adversity. The guide aims to equip people with practical skills to help cope with stress. A few minutes each day are enough to practice the self-help techniques. The guide can be used alone or with the accompanying audio exercises.

GuideMental Health and Neurological Conditions

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> WHO Technical specifications for automated non-invasive blood pressure measuring devices with cuff <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Health Organization

WHO Technical specifications for automated non-invasive blood pressure measuring devices with cuff

Report

27 Apr 2020

The document updates WHO’s 2005 guidance on blood pressure measuring devices (BPMDs). It also responds to concern about the lack of accurate, good-quality devices, especially in low-and middle-income countries (LMIC) through technical consultation and expert review. The focus of the publication is on automated non-invasive BPMDs with cuff, including characteristics, regulatory requirements and s...

ReportPrimary health careHarmful use of alcoholHousehold and Outdoor Air PollutionPhysical inactivity+2

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> HEARTS D: diagnosis and management of type 2 diabetes <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Health Organization

HEARTS D: diagnosis and management of type 2 diabetes

Guide

27 Apr 2020

This new HEARTS – D module on Diagnosis and management of type 2 diabetes complements and expands the diabetes section of the HEARTS Technical Package developed for use in primary health-care facilities to improve cardiovascular health. This module brings together WHO guidance on diagnosis, classification and management of type 2 diabetes in one document. It is aligned with the WHO Package of Es...

GuideDiabetesHealth system strengthening, including governance and financingPrimary health careHarmful use of alcohol+3

Access

<!-- THEME DEBUG --> <!-- THEME HOOK: 'field' --> <!-- FILE NAME SUGGESTIONS: ▪️ field--node--title--pin.html.twig ✅ field--node--title.html.twig ▪️ field--node--pin.html.twig ▪️ field--title.html.twig ▪️ field--string.html.twig ▪️ field.html.twig --> <!-- 💡 BEGIN CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' --> Addressing noncommunicable diseases in the COVID-19 response <!-- END CUSTOM TEMPLATE OUTPUT from 'themes/custom/whokap/templates/field/field--node--title.html.twig' -->

World Health Organization

Addressing noncommunicable diseases in the COVID-19 response

Guide

22 Apr 2020

People with underlying noncommunicable diseases (NCDs) such as hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer have a high risk for developing severe and even fatal COVID-19. It is important for them to strictly follow basic protective measures and make sure their chronic diseases are well managed. However, pandemics cripple health systems and compromise prov...

GuideCommunicable diseasesHealth system strengthening, including governance and financingPrimary health care

Access

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Read More